Article Details

AstraZeneca's Fasenra Flunks Late-Stage Trial In Patients With Esophagus ... - Yahoo Finance

Retrieved on: 2022-10-25 16:42:34

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Fasenra Flunks Late-Stage Trial In Patients With Esophagus ... - Yahoo Finance. View article details on hiswai:

Excerpt

AstraZeneca Plc (NASDAQ: AZN) has reported topline data from the MESSINA Phase 3 trial Fasenra (benralizumab) in Eosinophilic esophagitis (EoE) ...

Article found on: www.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up